Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases.

British journal of haematology·2024
Same author

Driving performance of outpatients achieving discharge criteria after deep sedation is worse than these of their escort-driver: a prospective observational study on simulator.

Acta gastro-enterologica Belgica·2023
Same author

[Impact of COVID-19 outbreak on domestic violence and child abuse].

Revue medicale de Liege·2021
Same author

[Interscalene block and shoulder surgery. Literature review and new method of infiltration].

Revue medicale de Liege·2021
Same author

[How I explore… hémostatic abnormalities in pediatrics].

Revue medicale de Liege·2021
Same author

[About a pediatric patients cohort followed in the adult rheumatology department of CHU Liège].

Revue medicale de Liege·2021

Related Experiment Videos

[Pediatric anesthesia: little children, big problems].

V Grosjean1, F Veyckemans, M C Seghaye

  • 1Service d'Anesthésie-Réanimation, CHU de Liège, Belgique. val.grosjean@gmail.com

Revue Medicale De Liege
|May 13, 2011
PubMed
Summary
This summary is machine-generated.

Ambulatory procedures offer benefits for pediatric patients. However, premature infants and children with sleep apnea or respiratory infections require careful anesthetic management to mitigate risks.

Related Experiment Videos

Area of Science:

  • Pediatric Anesthesiology
  • Ambulatory Surgery

Context:

  • Infants and children undergoing procedures in an ambulatory setting.
  • Identification of high-risk pediatric populations for ambulatory surgery.

Purpose:

  • To provide guidance on optimal anesthetic management for at-risk pediatric patients in the ambulatory setting.
  • To highlight specific risk factors in infants and children.

Summary:

  • Premature infants and children with sleep apnea or recent upper respiratory infections are identified as high-risk groups.
  • The paper offers recommendations for anesthetic management tailored to these vulnerable pediatric populations.
  • Focuses on optimizing safety and outcomes for pediatric patients undergoing outpatient procedures.

Impact:

  • Aims to improve the safety and efficacy of ambulatory anesthesia for infants and children.
  • Provides essential information for anesthesiologists managing pediatric patients.
  • Contributes to best practices in pediatric outpatient surgical care.